Page last updated: 2024-09-03

n(6)-carboxymethyllysine and Epiretinal Membrane

n(6)-carboxymethyllysine has been researched along with Epiretinal Membrane in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biswas, J; Kumar, SK; Miriam, KC; Nagaraj, RH; Ramakrishnan, S; Sulochana, KN; Swamy-Mruthinti, S1
Alt, A; Bretzel, RG; Clausen, JT; Hammes, HP; Hoerauf, H; Laqua, H; Schleicher, E1

Other Studies

2 other study(ies) available for n(6)-carboxymethyllysine and Epiretinal Membrane

ArticleYear
Immunolocalization and quantification of advanced glycation end products in retinal neovascular membranes and serum: a possible role in ocular neovascularization.
    Current eye research, 2002, Volume: 25, Issue:3

    Topics: Adolescent; Adult; Blood Glucose; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Epiretinal Membrane; Female; Glycation End Products, Advanced; Humans; Immunoenzyme Techniques; Lysine; Male; Middle Aged; Pyruvaldehyde; Retinal Neovascularization; Retinal Vasculitis

2002
N(epsilon)(carboxymethyl)lysin and the AGE receptor RAGE colocalize in age-related macular degeneration.
    Investigative ophthalmology & visual science, 1999, Volume: 40, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Epiretinal Membrane; Female; Glycation End Products, Advanced; Humans; Immunoenzyme Techniques; Lysine; Macular Degeneration; Male; Membrane Proteins; NF-kappa B; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Retinal Neovascularization

1999